References
- Ge PL, Du SD, Mao YL. Advances in preoperative assessment of liver function. Hepatob Pancreat Dis Int. 2014;13(4):361–370.
- Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84(2):355–373.
- de Graaf W, Hausler S, Heger M, et al. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol. 2011;54(4):738–745.
- Zarrinpar A, Lee C, Noguchi E, et al. A rapid, reproducible, noninvasive predictor of liver graft survival. J Surg Res. 2015;197(1):183–190.
- Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection? Dig Surg. 2012;29(1):6–17.
- Hashimoto M, Watanabe G. Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res. 2000;92(2):222–227.
- Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191(4):381–388.
- Garcea G, Ong SL, Maddern GJ. Predicting liver failure following major hepatectomy. Dig Liver Dis. 2009;41(11):798–806.
- Lau H, Man K, Fan ST, et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84(9):1255–1259.
- Thomas MN, Weninger E, Angele M, et al. Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements. HPB (Oxford). 2015;17(6):471–476.
- Hori T, Iida T, Yagi S, et al. K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transplant. 2006;12(4):605–613.
- Du Z, Wei Y, Chen K, et al. Risk factors and criteria predicting early graft loss after adult-to-adult living donor liver transplantation. J Surg Res. 2014;187(2):673–682.
- Hori T, Ogura Y, Yagi S, et al. How do transplant surgeons accomplish optimal portal venous flow during living-donor liver transplantation? Noninvasive measurement of indocyanine green elimination rate. Surg Innov. 2014;21(1):43–51.
- Olmedilla L, Perez-Pena JM, Ripoll C, et al. Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transplant. 2009;15(10):1247–1253.
- Schneider L, Spiegel M, Latanowicz S, et al. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation. Hepatob Pancreat Dis Int. 2011;10(4):362–368.
- Levesque E, Hoti E, Azoulay D, et al. Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation. Clin Transplant. 2011;25(2):297–301.
- Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest. 2002;122(5):1715–1720.
- Inal MT, Memis D, Kargi M, et al. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients. J Crit Care. 2009;24(3):329–334.
- Merle U, Sieg O, Stremmel W, et al. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterol. 2009;9:91.
- Zipprich A, Kuss O, Rogowski S, et al. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut. 2010;59(7):963–968.